Core Thesis - The Chemours Company presents a contrarian investment opportunity characterized by cyclical recovery, structural growth, and attractive valuation despite ongoing PFAS litigation concerns [2][5]. Valuation and Market Sentiment - As of February 24th, Chemours' share price was $18.41, with trailing and forward P/E ratios of 61.78 and 7.20 respectively [1]. - The company's valuation stands at 0.31x sales, significantly below the industry average of 1.08x, reflecting market pessimism and discounting much of the legal risk associated with PFAS litigation [2][3]. Business Strengths and Growth Potential - Chemours' core operations, particularly the Opteon refrigerants business and Advanced Performance Materials segment, are well-positioned for growth driven by increasing demand from data centers and the semiconductor industry [3]. - These end markets are expected to provide durable tailwinds that could lead to substantial revenue and margin expansion in the coming years [3]. Litigation and Future Outlook - The company is navigating through the PFAS litigation cycle, with 2026 anticipated to be a pivotal year as settlement visibility improves, potentially alleviating a major uncertainty that has impacted the stock [4]. - For investors willing to accept legal risks, Chemours offers access to high-quality businesses at deeply discounted valuations, creating a compelling risk/reward scenario [4][5]. Investment Considerations - The combination of an undervalued stock, structurally growing end markets, and the potential resolution of PFAS liabilities presents an attractive entry point for long-term investors seeking both value and growth upside [5]. - Positive developments regarding litigation settlements or operational execution could lead to a significant rerating of Chemours' shares [5].

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Marriott Vacations Worldwide Corporation - VAC [Accessibility Statement] Skip NavigationNEW YORK, Feb. 26, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Marriott Vacations Worldwide Corporation ("Marriott Vacations" or the "Company") (NYSE: VAC). Such investors are advised to contact Danielle Peyton at [[email protected]] or 646-581-9980, ext. 7980.The investigation concerns whether Marrio ...

GREENWICH, Conn., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Gabelli Funds will host its 17th Annual Specialty Chemicals Symposium in Midtown Manhattan, New York City on Thursday, March 19, 2026. The event will feature discussions with leading companies and organizations across the specialty chemicals ecosystem, with an emphasis on industry dynamics, current trends, and business fundamentals, as well as Specialty Chemicals investing. Attendees will also have the opportunity to participate in one-on-one meetings with ...

Shares of European chemicals company Chemours (NYSE: CC) fell 16.8% on Friday, as of 2:46 p.m. EDT. The chemicals giant reported lackluster earnings today and also provided guidance that merely met the analyst consensus. Thus, it's no surprise the stock found itself in the red after having doubled since late November. Still, opportunity may lurk one of Chemours' all-star up-and-coming products. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to bu ...

Management said TSS delivered record annual sales in 2025 despite subdued shipped residential stationary HVAC units. Dignam also stated that annual Opteon refrigerant sales grew 56% in 2025 and represented 75% of total refrigerant sales, up from 56% the prior year. Adjusted EBITDA margins in TSS were 32% for the year, up from 31%, even with about $22 million of additional R&D investment in liquid cooling and next-generation refrigerants.Chemours reported a fourth-quarter record for Opteon sales, with Opteon ...

Economic Data Summary - US economic growth in the fourth quarter of 2025 was reported at an annualized rate of 1.4%, significantly below the expected 2.9% [3][8][9] - The "core" personal consumption expenditures (PCE) index, the Federal Reserve's preferred inflation measure, increased by 0.4% in December, surpassing economists' expectations of 0.3% [4][5][6] - On an annual basis, the headline PCE rose by 2.9% and the core PCE by 3.0% in December, both slightly above forecasts [6] Market Reactions - S&P 500 futures fell approximately 0.3%, Dow Jones Industrial Average futures decreased by 0.2%, and Nasdaq 100 futures dropped by 0.5% [2] - Concerns about the private credit sector were heightened following Blue Owl's halt to withdrawals, which raised fears of a potential financial crisis [3] Company-Specific Updates - Chemours Co. reported a loss of $47 million in its fourth quarter earnings, leading to a 9% decline in its stock price [11][13] - Grail's stock plummeted over 40% after disappointing cancer trial results [12] - Live Nation's stock rose more than 3% following an 11% increase in fourth-quarter revenue to $6.31 billion, driven by a 12% gain in concert sales [13] - Opendoor's stock surged 14% after reporting a 46% increase in home acquisition volume, with revenue reaching $736 million, exceeding Wall Street estimates [16]

US stocks rose on Friday after the Supreme Court ruled that President Trump's sweeping "Liberation Day" tariffs are unlawful, saying he lacked the authority to impose them using emergency powers. The S&P 500 (^GSPC) and the Dow Jones Industrial Average (^DJI) both moved up 0.4%, coming off the end of a three-day winning streak on Thursday. The tech-exposed Nasdaq Composite (^IXIC) led the way higher, rising 0.6%. Stocks reversed course on the heels of the decision, having slid at the open as investors d ...

US stocks slid on Friday as investors digested economic data that showed US economic growth cooling in the fourth quarter, while the Fed's favored inflation gauge heated up to end last year. Wall Street also kept an eye out for US-Iran tensions, private credit jitters, and a potential Supreme Court tariff decision. The S&P 500 (^GSPC) moved down roughly 0.3%, while the Dow Jones Industrial Average (^DJI) fell by a steeper 0.4%, coming off the end of a three-day winning streak on Thursday. The Nasdaq Compo ...

分组1 - Innospec reported quarterly earnings of $1.5 per share, exceeding the Zacks Consensus Estimate of $1.26 per share, and showing an increase from $1.41 per share a year ago, resulting in an earnings surprise of +19.05% [1] - The company posted revenues of $455.6 million for the quarter ended December 2025, which was 4.39% below the Zacks Consensus Estimate and a decrease from $466.8 million year-over-year [2] - Innospec has surpassed consensus EPS estimates in all four of the last quarters and has topped consensus revenue estimates two times during the same period [2] 分组2 - The stock has increased approximately 13.1% since the beginning of the year, while the S&P 500 has declined by 0.1% [3] - The current consensus EPS estimate for the upcoming quarter is $1.35, with expected revenues of $460.6 million, and for the current fiscal year, the estimate is $5.71 on $1.88 billion in revenues [7] - The Zacks Industry Rank for Chemical - Diversified is in the bottom 18% of over 250 Zacks industries, indicating potential challenges for stock performance compared to higher-ranked industries [8]

Core Viewpoint - The competition for computing power in AI large models has intensified, with chip cooling becoming a hidden bottleneck for industry development. New materials and cooling solutions are essential for addressing the increasing power density of high-performance chips [2][4]. Group 1: Company Developments - Xin'an Co., a leader in organic silicon, has partnered with Canxiang Technology to launch an immersion liquid cooling solution, applying self-developed high-performance silicon-based cooling liquid to commercial immersion cooling platforms [2]. - The newly introduced ICL series immersion silicon-based liquid cooling products demonstrate Xin'an's long-term technological foundation, featuring excellent insulation, low viscosity for rapid heat dissipation, and environmental friendliness [5]. - Xin'an's shift from a raw material supplier to a comprehensive solution provider marks a significant transformation in the context of increasing competition in the traditional organic silicon market [7]. Group 2: Market Insights - The liquid cooling market in China is projected to reach 29.3 billion yuan by 2025, with the edge computing market expected to exceed 100 billion yuan [7]. - The phenomenon of high power density in chips is becoming more pronounced across various applications, including electric vehicles, data centers, humanoid robots, and power semiconductors, necessitating advanced cooling solutions [7]. Group 3: Technical Innovations - The immersion cooling solution allows high-performance AI servers to be fully submerged in a special silicon-based cooling liquid, breaking the physical limits of traditional air cooling technology [4]. - The current heat power density on AI processors has reached 1 kW/cm², significantly exceeding the temperatures found in rocket nozzles, highlighting the urgent need for innovative thermal management solutions [5]. - Future chip thermal management will focus on shortening thermal paths and reducing interface thermal resistance, potentially through the introduction of high thermal conductivity materials [8][9].